BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20458785)

  • 21. Carbimazole embryopathy: an emerging phenotype.
    Foulds N; Walpole I; Elmslie F; Mansour S
    Am J Med Genet A; 2005 Jan; 132A(2):130-5. PubMed ID: 15578620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severity of birth defects after propylthiouracil exposure in early pregnancy.
    Andersen SL; Olsen J; Wu CS; Laurberg P
    Thyroid; 2014 Oct; 24(10):1533-40. PubMed ID: 24963758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Scalp defects in infants of mothers treated for hyperthyroidism with methimazole or carbimazole during pregnancy.
    Milham S
    Teratology; 1985 Oct; 32(2):321. PubMed ID: 4049289
    [No Abstract]   [Full Text] [Related]  

  • 24. Comment on "Intrauterine diagnosis and management of fetal goiter: a case report".
    Bliddal S; Rasmussen AK; Sundberg K; Brocks V; Feldt-Rasmussen U
    J Clin Ultrasound; 2011 Jun; 39(5):276-8. PubMed ID: 21469148
    [No Abstract]   [Full Text] [Related]  

  • 25. Goitrogens.
    McLaren EH; Alexander WD
    Clin Endocrinol Metab; 1979 Mar; 8(1):129-44. PubMed ID: 85506
    [No Abstract]   [Full Text] [Related]  

  • 26. Carbimazole embryopathy-bilateral choanal atresia and patent vitello-intestinal duct: a case report and review of literature.
    Kannan L; Mishra S; Agarwal R; Kartikeyan V; Gupta N; Kabra M
    Birth Defects Res A Clin Mol Teratol; 2008 Sep; 82(9):649-51. PubMed ID: 18671255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperthyroidism and propylthiouracil-induced liver failure in pregnancy.
    Fung SC; Wyssusek KH
    Anaesth Intensive Care; 2015 Nov; 43(6):793-4. PubMed ID: 26603813
    [No Abstract]   [Full Text] [Related]  

  • 28. Propylthiouracil, and methimazole, and carbimazole-related hepatotoxicity.
    Akmal A; Kung J
    Expert Opin Drug Saf; 2014 Oct; 13(10):1397-406. PubMed ID: 25156887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapy of hypo- and hyperthyroidism in pregnancy].
    Lind P
    Acta Med Austriaca; 1997; 24(4):157-8. PubMed ID: 9441554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of hyperthyroidism in pregnancy with propylthiouracil and methimazole.
    Mujtaba Q; Burrow GN
    Obstet Gynecol; 1975 Sep; 46(3):282-6. PubMed ID: 51489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Choanal atresia: the result of maternal thyrotoxicosis or fetal carbimazole?
    Barwell J; Fox GF; Round J; Berg J
    Am J Med Genet; 2002 Jul; 111(1):55-6; discussion 54. PubMed ID: 12124735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Possible association between hyperthyroidism in pregnant women and obstructive congenital abnormalities of urinary tract in their offspring--a population-based case-control study.
    Bánhidy F; Puhó EH; Czeizel AE
    J Matern Fetal Neonatal Med; 2011 Feb; 24(2):305-12. PubMed ID: 20504076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review of antithyroid drug use during pregnancy and report of a case of aplasia cutis.
    Mandel SJ; Brent GA; Larsen PR
    Thyroid; 1994; 4(1):129-33. PubMed ID: 7519913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The safety of methimazole and propylthiouracil in pregnancy: a systematic review.
    Hackmon R; Blichowski M; Koren G
    J Obstet Gynaecol Can; 2012 Nov; 34(11):1077-1086. PubMed ID: 23231846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antithyroid drug use during pregnancy and the risk of birth defects in offspring: systematic review and meta-analysis of observational studies with methodological considerations.
    Morales DR; Fonkwen L; Nordeng HME
    Br J Clin Pharmacol; 2021 Oct; 87(10):3890-3900. PubMed ID: 33783857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of congenital anomalies associated with antithyroid treatment during pregnancy: a meta-analysis.
    Li X; Liu GY; Ma JL; Zhou L
    Clinics (Sao Paulo); 2015 Jun; 70(6):453-9. PubMed ID: 26106966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A new possible phenotype of carbimazole embryopathy: A case report].
    Mellerio H; Gay CL; Forest MG; Orgiazzi J; Nicolino M
    Arch Pediatr; 2010 May; 17(5):511-6. PubMed ID: 20395117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapy of endocrine disease: antithyroid drug use in early pregnancy and birth defects: time windows of relative safety and high risk?
    Laurberg P; Andersen SL
    Eur J Endocrinol; 2014 Jul; 171(1):R13-20. PubMed ID: 24662319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of maternal hyperthyroidism and antithyroid drug therapy on congenital malformation of newborn infants].
    Lian XL; Bai Y; Xu YH; Dai WX; Guo ZS
    Zhonghua Fu Chan Ke Za Zhi; 2005 Aug; 40(8):511-5. PubMed ID: 16202286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of maternal hyperthyroidism and fetal goiter].
    Bellini P; Marinetti E; Arreghini A; Andreotti C; Kirm V; Roncaglia N
    Minerva Ginecol; 2000; 52(1-2):25-7. PubMed ID: 10851860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.